← Back to Search

Sensory Testing and Brain Imaging for Menstrual Cramps

N/A
Waitlist Available
Led By Laura Payne, PhD
Research Sponsored by Mclean Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Female aged 13-19 years
Be younger than 65 years old
Must not have
Presence of factors indicative of secondary dysmenorrhea (e.g., self-reported presence of persistent pelvic pain throughout the month)
Current self-reported severe depression, bipolar disorder, panic disorder, or ADHD, or current treatment for these conditions
Timeline
Screening 3 weeks
Treatment Varies
Follow Up three time points during each of two study visits: during questionnaire completion (approx. 20 min. after arrival), immediately after the imaging session (approx. 90 min. after arrival), and following the final pain task (approx. 120 min after arrival)
Awards & highlights
No Placebo-Only Group

Summary

This trial will explore the connection between brain function, pain inhibition, and chronic pain in adolescent girls.

Who is the study for?
Adolescent girls aged 13-19 with regular menstrual cycles and period pain, who are right-handed, have a BMI of 35 or less, can read English, and have access to a smartphone or email. Parental consent is required for those under 18. Exclusions include severe mental health conditions, metal implants incompatible with MRI scans, chronic pain conditions like IBS, recent use of certain medications including stimulants and hormones.
What is being tested?
The study examines the brain's response to menstrual and non-menstrual pain in teens using sensory tests and fMRI scans. It aims to identify biomarkers predicting the development of persistent or chronic pain from primary dysmenorrhea (period pain without an organic cause) over two years.
What are the potential side effects?
There are no direct side effects from participating in this trial as it involves non-invasive testing such as Quantitative Sensory Testing and fMRI scanning. However, discomfort may arise from being in enclosed spaces during MRI scans.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a female between 13 and 19 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I experience pelvic pain all month, not just during my period.
Select...
I am currently experiencing severe depression, bipolar disorder, panic disorder, or ADHD, or am being treated for these.
Select...
I have been diagnosed with a chronic pain condition like IBS.
Select...
I have had pelvic inflammatory disease or an STD in the past.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~three time points during each of two study visits: during questionnaire completion (approx. 20 min. after arrival), immediately after the imaging session (approx. 90 min. after arrival), and following the final pain task (approx. 120 min after arrival)
This trial's timeline: 3 weeks for screening, Varies for treatment, and three time points during each of two study visits: during questionnaire completion (approx. 20 min. after arrival), immediately after the imaging session (approx. 90 min. after arrival), and following the final pain task (approx. 120 min after arrival) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in bodily pain from baseline to 12-months post baseline
Change in menstrual pain from baseline to 12-months post baseline
Conditioned pain modulation (CPM)
+6 more
Secondary study objectives
Change in bodily pain from 12-months post baseline to 24-months post baseline
Pain
Change in gray matter volume from baseline to 12-months post baseline
+7 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: fMRI and laboratory pain inductionExperimental Treatment2 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Quantitative Sensory Testing
2017
N/A
~950

Find a Location

Who is running the clinical trial?

Mclean HospitalLead Sponsor
217 Previous Clinical Trials
22,029 Total Patients Enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,068 Previous Clinical Trials
2,747,290 Total Patients Enrolled
Laura Payne, PhDPrincipal Investigator - Mclean Hospital
Mclean Hospital
1 Previous Clinical Trials
70 Total Patients Enrolled

Media Library

fMRI Clinical Trial Eligibility Overview. Trial Name: NCT04685343 — N/A
Period Pain Research Study Groups: fMRI and laboratory pain induction
Period Pain Clinical Trial 2023: fMRI Highlights & Side Effects. Trial Name: NCT04685343 — N/A
fMRI 2023 Treatment Timeline for Medical Study. Trial Name: NCT04685343 — N/A
~31 spots leftby Dec 2025